Live Breaking News & Updates on Biogeneration Ventures

Stay updated with breaking news from Biogeneration ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board

Tessellate BIO Announces Appointment of Professor Sandra Strauss to Scientific Advisory Board
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Noord Holland , San Diego , University College , New South Wales , United Kingdom , City Of , Andree Blaukat , Sue Charles , Chris Gardner , Sandra Strauss , National Cancer Registration , University College London , American Association For Cancer Research , London Sarcoma Service , University College London Hospital , Sarcoma Clinical Studies Group Bone Subgroup , Public Health England , Analysis Service , Children Medical Research Institute , Bone Sarcoma Group , Professor Sandra Strauss , Scientific Advisory , Synthetic Lethality , American Association , Cancer Research ,

Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients

Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Asahi Kasei Pharma , Amber Fennell , Ashley Tapp , Chris Freitag , Roberto Giugliani , Porto Alegre , Leiden University , Drug Administration , European Medicines Agency , Genetics Clinical Research Group , Healthcare Products Regulatory Agency , Medical Genetics Clinical Research Group , Hospital De Clinicas Porto Alegre , Lead Principal Investigator , Chief Medical Officer , States Food , Pediatric Disease Designations , Drug Designations , Tay Sachs Diseases , Track Designation , Medicines Agency , Medicinal Product Designation , Kingdom Medicines , Biogeneration Ventures ,

Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th annual WORLDSymposium™

Azafaros to present data from PRONTO study in patients with GM1 and GM2 gangliosidoses at the 20th annual WORLDSymposium™
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , United Kingdom , Asahi Kasei Pharma , Christian Freitag , Leiden University , Healthcare Products Regulatory Agency , European Medicines Agency , Drug Administration , Molecular Genetics , Lysosomal Storage , Chief Medical Officer , States Food , Pediatric Disease Designations , Drug Designations , Tay Sachs Diseases , Track Designation , Medicines Agency , Medicinal Product Designation , Kingdom Medicines , Biogeneration Ventures , Biomed Partners , Asahi Kasei Pharma Ventures ,

Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Roberto Giugliani , Porto Alegre , Drug Administration , Genetics Service , Leiden University , European Medicines Agency , Healthcare Products Regulatory Agency , Medical Genetics Service , Hospital Clinicas De Porto Alegre , Lead Principal Investigator , Daniel Almeida , Stefano Portolano , Rare Pediatric Disease Designations , United States Food , Orphan Medicinal Product Designation , Innovation Passport , United Kingdom Medicines , Fast Track Designation , Orphan Drug Designations , Tay Sachs Diseases , Niemann Pick , Biogeneration Ventures ,

Azafaros' Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolledTopline data from the study, exp. ....

United Kingdom , United States , Porto Alegre , Roberto Giugliani , Leiden University , European Medicines Agency , Drug Administration , Healthcare Products Regulatory Agency , Genetics Service , Azafaro Phase , Medical Genetics Service , Hospital Clinicas De Porto Alegre , Lead Principal Investigator , Daniel Almeida , Stefano Portolano , Rare Pediatric Disease Designations , United States Food , Orphan Medicinal Product Designation , Innovation Passport , United Kingdom Medicines , Fast Track Designation , Orphan Drug Designations , Tay Sachs Diseases , Niemann Pick , Biogeneration Ventures ,